Latest News in the pharma Industry

Policy & Regulation

FDA approves new drug to treat schizophrenia and bipolar disorder

FDA approves new drug to treat schizophrenia and bipolar disorder

22 Sep 2015

Vraylar is an atypical antipsychotic, for the acute treatment of manic or mixed episodes associated with bipolar I disorder and for treatment of schizophrenia in adults.

Read more 
Allergan confirms generic Rytary patent challenge

Allergan confirms generic Rytary patent challenge

21 Sep 2015

Allergan's ANDA product is a generic version of Impax Laboratories' Rytary.

Read more 
Impax receives FDA approval for generic version of Mestinon Timespan Tablets,     180 mg

Impax receives FDA approval for generic version of Mestinon Timespan Tablets, 180 mg

17 Sep 2015

First generic product approved from Hayward manufacturing facility following recent resolution of Warning Letter

Read more 
FDA establishes public docket to receive comments on enhancing the utility and usability of the inactive ingredient database

FDA establishes public docket to receive comments on enhancing the utility and usability of the inactive ingredient database

16 Sep 2015

FDA has announced the establishment of a public docket to receive comments from interested parties on enhancing the utility and usability of the Inactive Ingredient Database (IID) (also known as the Inactive Ingredient Guide). These comments will help ...

Read more 
FDA and EMA accept regulatory applications for Boehringer Ingelheim's Gilotrif for treatment of advanced SCC of the lung

FDA and EMA accept regulatory applications for Boehringer Ingelheim's Gilotrif for treatment of advanced SCC of the lung

27 Aug 2015

Read more 
Rx-360 summary of WHO Annex 5 technical supplemets

Rx-360 summary of WHO Annex 5 technical supplemets

24 Aug 2015

Read more 
Mylan statement in response to FDA warning letter relating to certain Agila facilities

Mylan statement in response to FDA warning letter relating to certain Agila facilities

21 Aug 2015

Read more 
Rx-360 summary of FDA Final Guidance Refuse to Accept Policy for 510(k)s

Rx-360 summary of FDA Final Guidance Refuse to Accept Policy for 510(k)s

21 Aug 2015

Read more 
Novartis Drug Odomzo Gains EU Approval for Locally Advanced Basal Cell Carcinoma

Novartis Drug Odomzo Gains EU Approval for Locally Advanced Basal Cell Carcinoma

20 Aug 2015

Read more 
TGA Approves First mAb Biosimilar

TGA Approves First mAb Biosimilar

20 Aug 2015

Read more 
Sprout Pharmaceuticals Receives FDA Approval of Addyl (Flibanserin 100 MG)

Sprout Pharmaceuticals Receives FDA Approval of Addyl (Flibanserin 100 MG)

19 Aug 2015

Read more 
Seattle Genetics Announces FDA Regular Approval of Adcetris (Brentuximab Vedotin) for Classical Hodgkin Lymphoma Patients

Seattle Genetics Announces FDA Regular Approval of Adcetris (Brentuximab Vedotin) for Classical Hodgkin Lymphoma Patients

18 Aug 2015

Read more